OBJECTIVE: The purpose of this study was to investigate whether folate intake is associated with risk for incident sporadic colorectal adenoma, and whether the association differs according to methylenetetrahydrofolate reductase (MTHFR) genotypes or is modified by intakes of alcohol or other micronutrients in the folate metabolism pathway. METHODS: The authors analyzed data from a colonoscopy-based case-control study (n = 177 cases, 228 controls) conducted in North Carolina between 1995 and 1997. RESULTS: The multivariate-adjusted odds ratio (OR) comparing the highest to lowest tertile of total folate intake was 0.61 (95% confidence interval [CI] 0.35-1.05); for MTHFR C677T polymorphism CT and TT genotypes relative to the CC genotype they were, respectively, 1.09 (CI: 0.71-1.66) and 0.68 (CI: 0.29-1.61); and for heavy drinkers (> 3 drinks/week) compared to non-drinkers it was 1.67 (CI: 1.00-2.81). The multivariate-adjusted ORs comparing the highest to lowest tertile of total folate intake according to those with the MTHFR CC, CT, and TT genotypes, were, respectively, 0.65 (CI: 0.30-1.39), 0.57 (CI: 0.23-1.44), and 0.22 (CI: 0.02-3.19). For those in the lowest tertile of folate intake who drank more than three drinks a week compared to those who were in the highest tertile of folate intake and did not drink alcohol the OR was 6.54 (CI: 1.96-21.80). There was no substantial evidence for interactions of folate with intakes of methionine, vitamins B2, B6, or B12. CONCLUSIONS: These data are consistent with hypotheses and previous findings that higher folate intake may reduce risk for colorectal neoplasms, perhaps especially among those who consume more alcohol. Copyright 2004 Kluwer Academic Publishers
OBJECTIVE: The purpose of this study was to investigate whether folate intake is associated with risk for incident sporadic colorectal adenoma, and whether the association differs according to methylenetetrahydrofolate reductase (MTHFR) genotypes or is modified by intakes of alcohol or other micronutrients in the folate metabolism pathway. METHODS: The authors analyzed data from a colonoscopy-based case-control study (n = 177 cases, 228 controls) conducted in North Carolina between 1995 and 1997. RESULTS: The multivariate-adjusted odds ratio (OR) comparing the highest to lowest tertile of total folate intake was 0.61 (95% confidence interval [CI] 0.35-1.05); for MTHFRC677T polymorphism CT and TT genotypes relative to the CC genotype they were, respectively, 1.09 (CI: 0.71-1.66) and 0.68 (CI: 0.29-1.61); and for heavy drinkers (> 3 drinks/week) compared to non-drinkers it was 1.67 (CI: 1.00-2.81). The multivariate-adjusted ORs comparing the highest to lowest tertile of total folate intake according to those with the MTHFR CC, CT, and TT genotypes, were, respectively, 0.65 (CI: 0.30-1.39), 0.57 (CI: 0.23-1.44), and 0.22 (CI: 0.02-3.19). For those in the lowest tertile of folate intake who drank more than three drinks a week compared to those who were in the highest tertile of folate intake and did not drink alcohol the OR was 6.54 (CI: 1.96-21.80). There was no substantial evidence for interactions of folate with intakes of methionine, vitamins B2, B6, or B12. CONCLUSIONS: These data are consistent with hypotheses and previous findings that higher folate intake may reduce risk for colorectal neoplasms, perhaps especially among those who consume more alcohol. Copyright 2004 Kluwer Academic Publishers
Authors: Michael Goodman; Roberd M Bostick; Myron Gross; Bharat Thyagarajan; Chiranjeev Dash; W Dana Flanders Journal: Ann Epidemiol Date: 2010-12 Impact factor: 3.797
Authors: Maureen A Murtaugh; Karen Curtin; Carol Sweeney; Roger K Wolff; Richard Holubkov; Bette J Caan; Martha L Slattery Journal: Cancer Causes Control Date: 2007-01-23 Impact factor: 2.506
Authors: Aditi Hazra; Charles S Fuchs; Takako Kawasaki; Gregory J Kirkner; David J Hunter; Shuji Ogino Journal: Cancer Causes Control Date: 2010-03 Impact factor: 2.506
Authors: A Joan Levine; Kristin Wallace; Shirley Tsang; Robert W Haile; Fred Saibil; Dennis Ahnen; Bernard F Cole; Elizabeth L Barry; David J Munroe; Iqbal U Ali; Per Ueland; John A Baron Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-09 Impact factor: 4.254
Authors: Jane C Figueiredo; A Joan Levine; Maria V Grau; Oivind Midttun; Per M Ueland; Dennis J Ahnen; Elizabeth L Barry; Shirley Tsang; David Munroe; Iqbal Ali; Robert W Haile; Robert S Sandler; John A Baron Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-08 Impact factor: 4.254
Authors: E Taioli; M A Garza; Y O Ahn; D T Bishop; J Bost; B Budai; K Chen; F Gemignani; T Keku; C S P Lima; L Le Marchand; K Matsuo; V Moreno; J Plaschke; M Pufulete; S B Thomas; G Toffoli; C R Wolf; C G Moore; J Little Journal: Am J Epidemiol Date: 2009-10-21 Impact factor: 4.897
Authors: A Joan Levine; Won Lee; Jane C Figueiredo; David V Conti; David J Vandenberg; Brian D Davis; Christopher K Edlund; Susanne M Henning; David Heber; Mariana C Stern; Robert W Haile Journal: Cancer Causes Control Date: 2011-01-28 Impact factor: 2.506